1. There are 102 EGFR-targeted drugs that are approved globally and in clinical research in total.

Up to now, there are 20 EGFR-targeted drugs approved by the global market (Europe, USA, Japan, South Korea, etc.), 80 in clinical application and research stage, and 2 in NDA application.

EGFR-targeted drugs

2. EGFR-targeted drugs are mainly small molecule inhibitors.

Molecular targeting drugs developed for EGFR are divided into two major categories:

1) There are 18 monoclonal antibodies, such as cetuximab and panitumumab. They can bind to EGFR extracellular region and block ligand-dependent EGFR activation.

2) There are 68 small molecule inhibitors, including small molecule multi-target receptor tyrosine kinase (RTKs) Inhibitors and small molecule tyrosine kinase inhibitors (EGFR-TKls), which can inhibit tyrosine kinase’s activity in EGFR intracellular region.

Small molecule inhibitors

3. 9 EGFR small molecule inhibitor drugs are approved.

1) AstraZeneca has 3 approved drugs, occupying one third of the global market.

2) The approved EGFR small molecule inhibitors are mainly sued for the treatment of non-small cell lung cancer.

9 EGFR small molecule inhibitor drugs are approved

3) In the United States, there are 8 approved EGFR small molecule inhibitor drugs which have patent protection. Gefitinib is confronting with patent cliff.

8 approved EGFR small molecule inhibitor drugs


4. 4 EGFR-targeted monoclonal antibodies are approved.

1) Antibody class EGFR-targeted drugs are mainly used for the treatment of rectal cancer, head and neck cancer.

2) Eli Lilly has 2 approved drugs, dominating the EGFR monoclonal antibody market.

3) Cetuximab is the champion of the year, with sales twice as much as panitumumab of the same indication.

4 EGFR-targeted monoclonal antibodies are approved.

Notes: The global sales showed in the histogram are the original sales of the relevant company. The above data was retrieved on July 12, 2017.





10 thoughts on “A Quick View of the Global R&D Situation of EGFR Drugs

  1. 229825 64460I discovered your weblog web site on google and verify some of your early posts. Continue to maintain up the superb operate. I simply extra up your RSS feed to my MSN News Reader. Looking for forward to reading extra from you in a whilst! 229491

  2. 436640 508750When I originally commented I clicked the -Notify me when new surveys are added- checkbox and from now on whenever a comment is added I purchase four emails sticking with the same comment. Maybe there is by any means you could get rid of me from that service? Thanks! 46975

  3. 889655 254070Ive applied the valuable points from this page and I can surely tell that it gives plenty of assistance with my present jobs. I would be quite pleased to keep finding back in this web page. Thank you. 902741

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>